Research Bio
Emil Scosyrev is an epidemiologist. His clinical research is focused on systemic chemotherapy for muscle-invasive bladder cancer, early detection of aggressive prostate cancer, chemoprevention of prostate cancer progression after definitive local therapy, and comparative analysis of clinical outcomes following different types of surgical interventions for prostate and kidney cancers. These projects are based on data collected at the University of Rochester Medical Center and at other academic institutions, as well as data from tumor registries and international clinical trials. In addition to clinical research in urologic oncology, Emil is involved in theoretical work on methodology of clinical trials and randomization-based inference.
2012
Ghazi A, Scosyrev E, Patel H, Messing E, Joseph J. "Complications associated with extraperitoneal robot assisted radical prostatectomy using the standardized Martin classification". Urology. 2012; . |
2012
Scosyrev E. "Identification of causal effects using instrumental variables in randomized trials with stochastic compliance". Biom J. 2012; . |
2012
Scosyrev E, Tobis S, Donsky H, Wu G, Joseph J, Rashid H, Messing E. "Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies." BJU Int.. 2012; . |
2012
Scosyrev E. "Interval estimation of treatment effects in randomized trials: when do confidence intervals have nominal coverage?". lnt Statist Rev. 2012; . |
2012
Tobis S, Venigalla S, Balakumaran K, Scosyrev E, Lloyd GL, Golijanin D, Joseph J, Rashid H, Wu G. "Analysis of a large single-center experience with robot-assisted pyeloplasty". Int J Urol. 2012; . |
